{"id":"W4283328755","doi":"10.1097/01.hs9.0000847280.69256.81","title":"P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Rituximab; Lenalidomide; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Phases of clinical research; Oncology; CD20; Gastroenterology; Clinical trial; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002009312,0.002548308,0.002833019,0.0006197571,0.0005938038,0.001616484,0.001742106,0.001738427,0.005792401],"category_scores_gemma":[0.0008194704,0.001080325,0.002212618,0.000508328,0.001398905,0.001304331,0.0005727442,0.005498718,0.001749488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001384458,"about_ca_system_score_gemma":0.00232459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001526002,"about_ca_topic_score_gemma":0.004080098,"domain_scores_codex":[0.9995828,0.0001575084,0.00001796989,0.00008409194,0.00004614164,0.000111444],"domain_scores_gemma":[0.9995224,0.00005867679,0.00008893607,0.00003820379,0.00003371212,0.000258091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8135797,0.09129884,0.001471835,0.001076624,0.001634406,0.0001563895,0.0002210461,0.001142819,0.02834874,0.000260743,0.003566869,0.05724199],"study_design_scores_gemma":[0.6992279,0.2921774,0.002989543,0.00004205074,0.0005845162,0.0001657281,0.0000568506,0.0006738373,0.002011718,0.0002046537,0.001834943,0.00003093939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843509,0.003690652,0.0007847063,0.0009027369,0.0003549316,0.004765683,0.001891001,0.000392123,0.002867275],"genre_scores_gemma":[0.9727615,0.004176694,0.003519922,0.001778807,0.0003128177,0.007018508,0.003783018,0.000109248,0.006539409],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005792401,"threshold_uncertainty_score":0.01937753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03182701236345815,"score_gpt":0.3023487328686932,"score_spread":0.270521720505235,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}